BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35077478)

  • 1. SPATS2 is positively activated by long noncoding RNA SNHG5 via regulating DNMT3a expression to promote hepatocellular carcinoma progression.
    Yan J; Huang QY; Huang YJ; Wang CS; Liu PX
    PLoS One; 2022; 17(1):e0262262. PubMed ID: 35077478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPATS2, negatively regulated by miR-145-5p, promotes hepatocellular carcinoma progression through regulating cell cycle.
    Dong G; Zhang S; Shen S; Sun L; Wang X; Wang H; Wu J; Liu T; Wang C; Wang H; Lu T; Rao B; Ren Z
    Cell Death Dis; 2020 Oct; 11(10):837. PubMed ID: 33037180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA SNHG5 promotes human hepatocellular carcinoma progression by regulating miR-363-3p/RNF38 axis.
    Hu PA; Miao YY; Yu S; Guo N
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3592-3604. PubMed ID: 32329834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPATS2 is correlated with cell cycle progression and immune cells infiltration in hepatocellular carcinoma.
    Lin J; Yan J; Deng XL; Wang CS; Wang HS
    BMC Gastroenterol; 2023 Jan; 23(1):8. PubMed ID: 36631750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA SNHG5 promotes human hepatocellular carcinoma progression by regulating miR-26a-5p/GSK3β signal pathway.
    Li Y; Guo D; Zhao Y; Ren M; Lu G; Wang Y; Zhang J; Mi C; He S; Lu X
    Cell Death Dis; 2018 Aug; 9(9):888. PubMed ID: 30166525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
    Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
    J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding LINC01551 promotes hepatocellular carcinoma cell proliferation, migration, and invasion by acting as a competing endogenous RNA of microRNA-122-5p to regulate ADAM10 expression.
    Gao J; Yin X; Yu X; Dai C; Zhou F
    J Cell Biochem; 2019 Oct; 120(10):16393-16407. PubMed ID: 31270840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA SNHG5 promotes the proliferation and cancer stem cell-like properties of HCC by regulating UPF1 and Wnt-signaling pathway.
    Li Y; Hu J; Guo D; Ma W; Zhang X; Zhang Z; Lu G; He S
    Cancer Gene Ther; 2022 Oct; 29(10):1373-1383. PubMed ID: 35338348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA RP11-909N17.2 promotes proliferation, invasion, and migration of hepatocellular carcinoma by regulating microRNA-767-3p.
    Liu Q; Dai SJ; Dong L; Li H
    Biochem Cell Biol; 2020 Dec; 98(6):709-718. PubMed ID: 33210543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA SNHG14 aggravates invasion and migration as ceRNA via regulating miR-656-3p/SIRT5 pathway in hepatocellular carcinoma.
    Tang SJ; Yang JB
    Mol Cell Biochem; 2020 Oct; 473(1-2):143-153. PubMed ID: 32607966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma.
    Tang YH; He GL; Huang SZ; Zhong KB; Liao H; Cai L; Gao Y; Peng ZW; Fu SJ
    Mol Oncol; 2019 May; 13(5):1296-1310. PubMed ID: 30943320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
    Zhao X; Liu Y; Yu S
    Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of LncDQ is Associated with Poor Prognosis and Promotes Tumor Progression via Epigenetic Regulation of the EMT Pathway in HCC.
    Zeng B; Lin Z; Ye H; Cheng D; Zhang G; Zhou J; Huang Z; Wang M; Cai C; Zeng J; Tang C; Liu J
    Cell Physiol Biochem; 2018; 46(3):1122-1133. PubMed ID: 29669339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
    Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
    J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma.
    Liu W; Zhang GQ; Zhu DY; Wang LJ; Li GT; Xu JG; Jin XL; Zhu YM; Yang XY
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7612-7620. PubMed ID: 32744687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of lncRNA FER1L4 suppresses the proliferation and migration of the hepatocellular carcinoma via regulating PI3K/AKT signal pathway.
    Wang X; Dong K; Jin Q; Ma Y; Yin S; Wang S
    J Cell Biochem; 2019 Apr; 120(4):6781-6788. PubMed ID: 30382631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of H19/miR-326 axis in hepatocellular carcinoma development through modulating TWIST1.
    Wei LQ; Li L; Lu C; Liu J; Chen Y; Wu H
    J Cell Physiol; 2019 Apr; 234(4):5153-5162. PubMed ID: 30362512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.
    Wang YG; Wang T; Shi M; Zhai B
    J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma.
    Tang S; Hu W; Hu J; Wu S; Li J; Luo Y; Cao M; Zhou H; Jiang X
    Liver Int; 2015 Feb; 35(2):608-19. PubMed ID: 24423280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.